1928 Diagnostics Awarded as Technology Pioneer by World Economic Forum


Two of the founders of 1928 Diagnostics. Kristina Lagerstedt, CEO, and Susanne Staaf, COO.

1928 Diagnostics, Gothenburg-based Swedish company was selected when World Economic Forum on Thursday announced its selection of the world’s 61 most promising Technology Pioneers 2018, the most diverse class of such pioneers ever. Companies were selected for their potential to “transform society and industry” and “shape the Fourth Industrial Revolution,” Fulvia Montresor of the World Economic Forum said.

Antibiotic resistance is a major threat against humanity and 1928 Diagnostics' contribution to fight antibiotic resistance is their powerful and fully automated platform for analysis of the complete genetic code of bacteria. 1928 Diagnostics made it to the selection for its contributions in the field of Health.

“We welcome 1928 Diagnostics in this diverse group of technology pioneers,” says Fulvia Montresor, Head of Technology Pioneers at the World Economic Forum. “1928 Diagnostics and its fellow pioneers are front and centre in shaping the ongoing Fourth Industrial Revolution and we believe they will be transforming society and industry in a positive way in the years to come.”

“It's a true honor to be acknowledged as a Tech pioneer by the World Economic Forum in this selection of impressive companies worldwide. The award encourages the 1928 Diagnostics team to work even harder to erase and/or bridge the gap between DNA technology and infection control, an effort that will ultimately save many lives. At the same time we want to use this opportunity to leverage the importance of global collaboration to save the power of antibiotics and fight antibiotic resistant bacteria – one of the greatest threats against humanity”, says CEO Kristina Lagerstedt of 1928 Diagnostics.

Click here to read the full press release.